Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation

Blood

Volumn 94, Issue 2, 1999, Pages 455-464

  Ringden O ^a   Remberger, M ^b   Runde, V ^b   Bornhauser M ^b   Blau, I W ^b   Basara, N ^b   Holig K ^b   Beelen, D W ^b   Hagglund H ^b   Basu, O ^b   Ehninger, G ^b   Fauser, A A ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSIDE; BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MELPHALAN; METHOTREXATE; OKT 3; PREDNISOLONE; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0033566347     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.455.414k08_455_464     Document Type: Article

References (46)

1. Dreger P, Suttorp M, Haferlach T, Löffler H, Schmitz N, Schroyes W: Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404, 1993
2. Russel NH, Hunter AE: Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 13:353, 1994
3. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
4. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S. Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
5. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russel NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF). Blood 85:1666, 1995
6. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794, 1996
7. Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte J-P, Brinch L, Cook G, Deliliers GL, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A, on behalf of the European Group for Blood and Marrow Transplantation (EBMT): Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 95:715, 1996
8. +-selected peripheral blood cells. Exp Hematol 26:415, 1998
9. Bacigalupo A, Zikos P, Van Lint M-T, Valbonesi M, Lamparelli T, Gualandi F, Occhini D, Mordini N, Bregante S, Berisso G, Vitale V, Sessarego M, Marmont AM: Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: A single-center experience. Exp Hematol 26:409, 1998
10. Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringdén O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Rüssel NH, Gratwohl A: Allogeneic bone marrow transplantation vs. Filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 21:995, 1998
11. Ringdén O, Lönnqvist B, Hägglund H, Ljungman P, Shanwell A, Lawlor E, Schmitz N: Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease (letter). Bone Marrow Transplant 16:856, 1995
12. Stockschläder M, Löliger C, Krüger W, Zeller W, Heyll A, Schönrock-Nabulsi P, Zander A: Transplantation of allogeneic rhG-CSF mobilized peripheral CD34+ cells from an HLA-identical unrelated donor. Bone Marrow Transplant 16:719, 1995
13. Ringdén O, Hägglund H, Runde V, Basu O, Kroschinsky F, Stockschläder M, Potter MN: Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors. Bone Marrow Transplant 21:S81, 1998(suppl 3)
14. Hägglund H, Ringdén O, Remberger M, Lönnqvist B, Sparrelid E, Tammik L, Kumlien G: Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant 22:131, 1998
15. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD: The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883, 1993
16. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H, Müller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
17. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992
18. Bornhäuser M, Hölig K, Rautenberg U, Ordemann R, Kroschinsky F, Naumann R, Schuler U, Ehninger G: Allogeneic transplantation of G-CSF mobilised CD34 positive selected peripheral blood stem cells from unrelated and HLA-mismatched donors. Blood 90:106a, 1997 (abstr, suppl 1)
19. Ringdén O, Remberger M, Persson U, Ljungman P, Aldener A, Andström E, Aschan J, Bolme P, Dahllöf G, Dalianis T, Gahrton G, Hägglund H, Lönnqvist B, Olerup O, Shanwell A, Sparrelid E, Winiarski J, Öberg M, Möller E: Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 15:619, 1995
20. Beelen DW, Ottinger HD, Elmaagacli A, Scheulen B, Basu O, Kremens B, Havers W, Grosse-Wilde H, Schaefer U: Transplantation of Filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternatively family donors in patients with hematologic malignancies: A prospective comparison of clinical outcome, immune reconstitution and hematopoietic chimerism. Blood 90:4725, 1997
21. Storb R, Deeg HJ, Farewell K, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Lum L, Martin P, McGuffin R, Sanders J, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119, 1986
22. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. Parts I and II. N Engl J Med 292:832, 895, 1975
23. Shulman HM, Sullivan KM, Weiden Pl, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi M-S, Storb R, Thomas ED: Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204, 1980
24. Einsele H, Steidle M, Valbracht A, Saal J, Ehringer G, Müller C: Early occurrence of HCMV infection after BMT as demonstrated by the PCR technique. Blood 77:1104, 1991
25. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1, 1977
26. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187, 1972
27. Ringdén O, Bäckman L, Lönnqvist B, Heimdahl A, Lindholm A, Bolme P, Gahrton G: A randomized trial comparing the use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies. Bone Marrow Transplant 1:41, 1986
28. Hägglund H, Ringdén O, Öhman S, Remberger M, Carlens S, Mattsson J: A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation. Bone Marrow Transplant (in press)
29. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J: CD34+ cell dose predicts survival, posttransplant morbidity and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88:3223, 1996
30. Ringdén O, Deeg HJ, Beschorner W, Slavin S: Effector cells of graft-versus-host disease, host resistance and the graft-versus-leukemia effect: Summary of a workshop on bone marrow transplantation. Transplant Proc 19:2758, 1987
31. Marmont A, Horowitz MM, Gale RP, Ash RC, van Bekkum DW, Champlin RE, Dicks KA, Goldman JM, Good RA, Herzig RM, Hung R, Masaoke T, O'Reilly RD, Prentice HG, Rimm AA, Ringdén O, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
32. Ringdén O, Nilsson B: Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation 40:39, 1985
33. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Buckner CD, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443, 1991
34. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McGullough J, McGlave P, Perkins HA, Philips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:592, 1993
35. Ringdén O, Remberger M, Carlens S, Hägglund H, Mattsson J, Aschan J, Lönnqvist B, Klaesson S, Winiarski J, Dalianis T, Olerup O, Sparrelid E, Svahn BM, Ljungman P: Low incidence of acute graft-versus-host disease, using unrelated HLA-A, -B and -DR compatible donors and conditioning including anti-T-cell antibodies. Transplantation 66:620, 1998
36. Ringdén O, Pihlstedt P, Markling L, Aschan J, Båryd I, Ljungman P, Lönnqvist B, Tollemar J, Janossy G, Sundberg B: Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 7:221, 1991
37. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
38. Ringdén O, Paulin T, Lönnqvist B, Nilsson B: An analysis of factors predisposing for chronic graft-versus-host disease. Exp Hematol 13:1062, 1985
39. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR: Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90:4705, 1997
40. Scott MA, Gandhi MK, Jestice HK, Mahendra P, Bass G, Marcus RE: A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: A case-controlled study. Bone Marrow Transplant 22:273, 1998
41. Weiden PL, Fluornoy N, Thomas ED, Prentice R, Feifer A, Buckner CD, Storb R: Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300:1068, 1979
42. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 75:555, 1989
43. Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC for the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Bone Marrow Transplant 18:921, 1996
44. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H: Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775, 1996
45. Becker PS, Wagle M, Matous S, Swanson, RS, Pihan G, Lowry PA, Stewart FM, Heard SO: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 3:45, 1997
46. Anderlini P, Przepiorka D, Körbling M, Champlin R: Blood stem cell procurement: Donor safety issues. Bone Marrow Transplant 21:S35, 1998 (suppl 3)